Ontology highlight
ABSTRACT: Background
To evaluate the non-inferiority of low dose efavirenz (400 mg) to standard dose efavirenz (600 mg), when taken in combination with tenofovir and lamivudine in Indian patients with HIV-1 infection.Methods
An open-label, interventional phase IV study with blinded assessment was conducted across 17 sites in India. HIV-1-infected antiretroviral therapy-naive adult patients (≥18 years of age) with a plasma HIV-1 viral load of at least 1000 copies per mL were randomized to receive either tenofovir/lamivudine/efavirenz (TLE) 400 or TLE 600. The primary endpoint was the difference in the proportion of patients achieving < 200 copies per mL at the end of 24 weeks.Results
A total of 265 patients were enrolled and were randomized in 1:1 ratio to TLE 400 group (130 p
SUBMITTER: Dravid A
PROVIDER: S-EPMC9726289 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature